Genmab: A Rising Star In Biotech [Seeking Alpha]
Genmab A/S - American Depositary Shares (GMAB)
Company Research
Source: Seeking Alpha
Genmab: A Rising Star In Biotech Summary The Netflixes of tomorrow are here today (Part 2). My 2029 list of elite performers will include a number of bio tech participants. My second choice for the 2029 list of elite performers: Genmab A/S. Creating a list of companies that will make my elite list of 2029 investments that will have increased in value by a factor of 10 or more is a major challenge for more than one reason. As I stated in my previous article, in our fast moving world, industries unknown today may be household names in ten years. Millennials, which make up a quarter of the population of the United States, have no brand loyalty. This is proven by the fact that 33 million households cut their cable cord last year, that more companies closed their doors last year than during the 2008 recession, and that E Sports is more popular with them than MLB, the NBA, the NHL, and the NFL. (Source: Evercore ISI, Initiating Coverage for Internet: Appetite for disruption, December 5, 201
Show less
Read more
Impact Snapshot
Event Time:
GMAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMAB alerts
High impacting Genmab A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GMAB
News
- BioNJ Unveils "Time Off for Clinical Trials" Initiative [Yahoo! Finance]Yahoo! Finance
- Genmab A/S (NASDAQ: GMAB) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, up previously from $46.00.MarketBeat
- High Growth Tech Stocks To Watch In November 2024 [Yahoo! Finance]Yahoo! Finance
- Genmab Announces Financial Results for the First Nine Months of 2024 [Yahoo! Finance]Yahoo! Finance
- Genmab Announces Financial Results for the First Nine Months of 2024GlobeNewswire